Manage Tickers

Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current
Analyst Rating Guide

News

Back

Cryo-Cell Announced Transfer to the NYSE American Stock Exchange

Author: Charles Gross | August 17, 2022 05:07pm
Cryo-Cell International, Inc. (The Nasdaq Stock Market Symbol: CCEL) ("Cryo-Cell", the "Company"), the world's first private cord blood bank to separate and store stem cells in 1992, announced today that it will change its listing from the Nasdaq Capital Market to the NYSE American stock exchange on August 30, 2022. The last date of trading on the Nasdaq Capital Market is expected to be August 29. 2022. Cryo-Cell's common stock will continue to trade under its existing "CCEL" symbol.

Posted In: CCEL


CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION

CORE Finalist